51 results
424B3
BIAF
BioAffinity Technologies Inc
22 May 24
Prospectus supplement
4:00pm
; and
Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over … the registrant’s ability to record, process, summarize and report financial information; and
Any fraud, whether or not material, that involves
424B3
BIAF
BioAffinity Technologies Inc
22 May 24
Prospectus supplement
4:00pm
are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
Any fraud, whether … ability to record, process, summarize and report financial information; and
Any fraud, whether or not material, that involves management or other employees
424B3
BIAF
BioAffinity Technologies Inc
16 Apr 24
Prospectus supplement
7:19pm
, partners, and vendors may engage in misconduct or other improper activities.
Failure to comply with healthcare fraud and abuse laws and regulations … , third-party payors, and customers will be subject, directly or indirectly, to federal and state healthcare fraud and abuse laws, false claims laws
POS AM
qigxnbm
1 Apr 24
Prospectus update (post-effective amendment)
8:06pm
D
23hda
20 Mar 24
$2.62 mm in equity / options / securities to be acquired, sold $2.62 mm, 3 investors
2:24pm
8-K
EX-1.1
wivftp0m9dng kgght
8 Mar 24
Entry into a Material Definitive Agreement
5:00pm
8-K
EX-10.1
j2wf 6xv87pt5vxl6
8 Mar 24
Entry into a Material Definitive Agreement
5:00pm
424B5
az4kib2mwqc1w1t4
8 Mar 24
Prospectus supplement for primary offering
12:18pm
424B5
ubqmmk8zz v8s6cdn
7 Mar 24
Prospectus supplement for primary offering
9:57pm
424B5
g0fqd8bqmc33xm80sn
28 Nov 23
Prospectus supplement for primary offering
4:00pm
S-3
rkt6cys 1y
16 Nov 23
Shelf registration
5:23pm